Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis. - Wikidata - awgldk - TriplyDB

Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis.

Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis.

http://www.wikidata.org/entity/Q33442776

about

Recent advancement of therapeutic endoscopy in the esophageal benign diseases Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies.Reflux symptoms and side effects among patients with gastroesophageal reflux disease at baseline, during treatment with PPIs, and after Nissen fundoplication.Efficacy of Magnetic Sphincter Augmentation versus Nissen Fundoplication for Gastroesophageal Reflux Disease in Short Term: A Meta-Analysis.Treatment of GORD: Three decades of progress and disappointments Use of proton pump inhibitors after antireflux surgery: a nationwide register-based follow-up study.Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis.Long term quality of life after laparoscopic antireflux surgery for the elderly.Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting.Cost-effectiveness of proton pump inhibitors versus laparoscopic Nissen fundoplication for patients with gastroesophageal reflux disease: a systematic review of the literature.Gastro-oesophageal reflux. Part 3: medical and surgical treatment.Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis.Stretta Radiofrequency Treatment for GERD: A Safe and Effective Modality.Evaluation of clinical outcome after laparoscopic antireflux surgery in clinical practice: still a controversial issue.Adult and paediatric GERD: diagnosis, phenotypes and avoidance of excess treatments.A Review of New Surgical and Endoscopic Therapies for Gastroesophageal Reflux Disease.Does Nissen Fundoplication Provide Lifelong Reflux Control? Symptomatic Outcome After 31-33 Years.Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease.Tri-comparison of Laparoscopic Nissen, Hill, and Nissen-Hill Hybrid Repairs for Uncomplicated Gastroesophageal Reflux Disease.New Approaches to Gastroesophageal Reflux Disease.What you need to know when you prescribe a proton pump inhibitor.LATE EVALUATION OF PATIENTS OPERATED FOR GASTROESOPHAGEAL REFLUX DISEASE BY NISSEN FUNDOPLICATION.Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression Esophageal malignancy: a growing concern Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study.Preoperative factors predicting clinical outcome following laparoscopic fundoplication.Weight gain in mice on a high caloric diet and chronically treated with omeprazole depends on sex and genetic background.Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD.Effects of omeprazole or anti-reflux surgery on lower oesophageal sphincter characteristics and oesophageal acid exposure over 10 years.Proton-pump inhibitors among adults: a nationwide drug-utilization study.Study of the prevalence of gastroesophageal reflux symptoms and the role of each in relation to the GERD Impact Scale, based on a population of patients admitted for laparoscopic surgery compared to a control group.Barrett's esophagus: surgical treatments Spotlight on the Linx™ Reflux Management System for the treatment of gastroesophageal reflux disease: evidence and research

P2860

Q28081986-F55FC32B-F8B8-40A6-9B8D-D704C829E529 Q30249468-18F7DB9E-8614-4DEE-B1E5-DBF5C9AF72D3 Q30928614-08AB3333-2F78-4BFF-A064-0D402AD42BB0 Q33457312-2524F71C-7D10-4B86-8B2D-31B740706D21 Q33561533-9F70378F-F8A0-4397-8080-BE78DD6711FA Q33695362-451328D6-CECB-4332-BE97-3870E8F32C3E Q34237263-35061A6A-BF0F-458B-A7F7-BF4F9BAF9E06 Q36117874-6E52674C-37FA-4D5A-8B00-91F2E56975DA Q37364094-8047D83C-0C9E-4C6E-8D36-0949E40A5FD2 Q37378002-A7BC994E-13D1-47E4-80AD-62B3724EE4E0 Q37864586-4E3D5FB7-E0EC-473C-B9B2-BE80E1337280 Q38099167-D8C839AC-8868-4296-B85C-782CFB9A71AA Q38135722-5EABD031-EB96-41BD-8EF3-77298C1F2DEF Q38147076-4E21D093-45F0-479B-B949-21A91627C8CE Q38782420-665D4823-FF26-4CA2-88AD-EE0A417F7A1C Q38916823-40D3F5E8-6A85-4060-94E6-4B8554AD48DA Q38917902-0007A1BF-A36D-4591-BDB3-B89993E1633C Q39158980-4413415A-5911-4FC4-AF4F-D741FF15C31C Q39181093-145A9CDB-EDB2-4BBC-915A-84E1F633D737 Q39215942-2D9A3AA1-C37C-45E6-98B8-5184B4188182 Q40169026-BB0D37DB-4135-400A-A06F-2AD43C7CD579 Q41060355-7A4436CE-A98B-4D18-B6A5-347A572048B8 Q41534087-F3BD169E-1CD9-4CE7-B276-A8B821E77E8A Q42371575-402E072D-C3F4-4BFC-BEE0-66F1672B1715 Q42394329-E4180D9D-28FE-444D-A3B5-D773324AD0BD Q45386150-E9B74728-9954-4541-9ACB-25A1BE7E2306 Q46192327-DF8B9ED3-3C5E-46F7-A8C8-2174F5B48E6C Q46464227-A4184980-2CDB-4C6A-B428-8F4C6B0255C4 Q47618072-30E0B1C0-75F2-4260-9FD5-77862BEB959A Q47639901-403C6419-30C1-453A-87D6-A8BA35E62BFE Q51824343-E2F7B482-275D-4905-A048-F8FDEEFBD7AF Q55289788-6A00A26D-30E2-4F72-AB70-6C0D844BFBA6 Q55645785-F1CDF63B-654A-468F-AD97-8D56315E18BA Q57546193-075CD290-70A4-4E41-9C5C-7484FD07072B Q58781538-C0BAC699-EC5F-4500-ADEA-FEDE15977E04

P2860

Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis.

http://www.wikidata.org/entity/Q33442776

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Comparison of outcomes twelve ...... herapy for reflux esophagitis.

@ast

Comparison of outcomes twelve ...... herapy for reflux esophagitis.

@en

type

label

Comparison of outcomes twelve ...... herapy for reflux esophagitis.

@ast

Comparison of outcomes twelve ...... herapy for reflux esophagitis.

@en

prefLabel

Comparison of outcomes twelve ...... herapy for reflux esophagitis.

@ast

Comparison of outcomes twelve ...... herapy for reflux esophagitis.

@en

P1433

Q33442776-2437664D-7707-46E5-AF32-8959EF4F144E

P1476

Q33442776-3087E8BA-C329-4F79-A2D7-730D15B7CED2

P2093

Q33442776-0276D7D8-D383-40F0-8CB3-441B3D404103

Q33442776-04A960FB-4957-452B-9197-26E95B1AFEBF

Q33442776-20B0C97E-2D25-4CCE-AA99-452186BAFBDD

Q33442776-2774C531-A966-4417-A526-193EBCB84B0A

Q33442776-36CAF05D-9359-4208-9DF0-0984154D8CAB

Q33442776-4489E986-60CC-43C8-833E-7150EA42C52D

Q33442776-54E446D9-9B29-4364-A65A-7953AE532246

Q33442776-7D0B5BE1-2A80-4CE0-8DD8-569AAB3D358A

Q33442776-7F474BFC-F3E3-45D4-9104-F6E1BB640573

Q33442776-947B6F6E-788C-4B80-80DD-BCAADC504D7B

P304

Q33442776-4EAEF6D1-A80E-42DF-B171-2743ADDADC22

P31

Q33442776-2E6B7CE3-B70D-4CCB-981F-E94DBEA69E09

P356

Q33442776-9FD34944-F555-40CE-9902-F6967CA8A240

P407

Q33442776-736ABF00-64F3-467B-9CE2-9E008820E03F

P433

Q33442776-BEAEA4B7-5A5D-4220-B1A1-71A4A6A3F046

P478

Q33442776-8956FD26-E276-4E6C-BD67-328593D64611

P50

Q33442776-344D5819-4AC0-4CDE-813F-3C3652732421

P577

Q33442776-0B830E76-082E-4F63-9DB5-3AFEB80089DD

P698

Q33442776-F3204F3F-200D-4AA0-87B0-EBE175B14722

P356

J.CGH.2009.05.021

P1433

Clinical Gastroenterology and Hepatology

P1476

Comparison of outcomes twelve ...... herapy for reflux esophagitis.

@en

P2093

Anders Malm

http://www.w3.org/2001/XMLSchema#string

Anders Walan

http://www.w3.org/2001/XMLSchema#string

Cecilia Engström

http://www.w3.org/2001/XMLSchema#string

Helge E Myrvold

http://www.w3.org/2001/XMLSchema#string

Lars Lundell

http://www.w3.org/2001/XMLSchema#string

Lene Wallin

http://www.w3.org/2001/XMLSchema#string

Madeline Montgomery

http://www.w3.org/2001/XMLSchema#string

Nordic GERD Study Group

http://www.w3.org/2001/XMLSchema#string

Pekka Miettinen

http://www.w3.org/2001/XMLSchema#string

Risto Julkunen

http://www.w3.org/2001/XMLSchema#string

P304

1292-8; quiz 1260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2009.05.021

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Jan Gunnar Hatlebakk

P577

2009-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19490952

http://www.w3.org/2001/XMLSchema#string